<DOC>
	<DOC>NCT00930488</DOC>
	<brief_summary>For each patient, an initial visit and at least one follow-up visit at the end of treatment should be documented by the treating physician in the case report form.</brief_summary>
	<brief_title>Treatment of Patients With Acute Sinusitis</brief_title>
	<detailed_description />
	<mesh_term>Sinusitis</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Norgestimate, ethinyl estradiol drug combination</mesh_term>
	<criteria>Any patient with a diagnosis of acute bacterial sinusitis treated with AveloxÂ® in accordance with the local production information. Those specified in the local product information contraindications and precautions must be considered.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Moxifloxacin</keyword>
	<keyword>MXF</keyword>
	<keyword>Avelox</keyword>
	<keyword>Sinusitis</keyword>
	<keyword>Acute bacterial sinusitis, ABS</keyword>
</DOC>